Company Profile

Curis Inc Stock Price, News & Analysis

Ticker:
CRIS
Exchange:
NASDAQ
Sector:
Biotechnology
Location:
Headquartered in the United States and listed on NASDAQ, Curis is followed within the biotech universe for its exposure to catalyst-driven execution.

Stock performance

0.36 USD (-15.49%)

Close

Last updated: June 23, 2026 at 00:00

14.1M USD

Market cap

Why the stock is moving

CRIS is trading with a steady catalyst profile while investors wait for the next headline that changes the story.

Company overview

Business overview

Curis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, Curis is followed within the biotech universe for its exposure to catalyst-driven execution.

Business Model Characteristics

Curis follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.

Position Within the Biotechnology Landscape

Compared with more mature healthcare peers, Curis sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.

Future catalysts

Recent news

The five most recent feed items are shown below in reverse chronological order.

  1. 01

    Curis Provides First Quarter 2026 Business Update

    Source: Curis Inc

  2. 02
  3. 03
  4. 04
  5. 05

    Curis Provides Fourth Quarter 2025 Business Update

    Source: Curis Inc

Similar stocks

Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

Frequently Asked Questions

What is the current stock price of Curis Inc (CRIS)?

Curis Inc (CRIS) most recently closed at 0.36 USD, a -15.49% move versus the previous session.

What is the market cap of Curis Inc (CRIS)?

Curis Inc currently has a market capitalization of 14.1M USD on BioPharmSignal.

What does Curis Inc do?

Curis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

On which exchange is CRIS stock listed?

Curis Inc (CRIS) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Curis is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.

What is Curis?

Curis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.

Which conditions is Curis Inc targeting with Curis?

Curis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

What is Investors?

Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.